A detailed history of Nebula Research & Development LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nebula Research & Development LLC holds 8,452 shares of JNJ stock, worth $1.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
8,452
Previous 4,446 90.1%
Holding current value
$1.3 Million
Previous $703 Million 75.65%
% of portfolio
0.2%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $578,386 - $632,066
4,006 Added 90.1%
8,452 $1.24 Billion
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $76,989 - $80,719
-496 Reduced 10.04%
4,446 $703 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $183,892 - $200,665
-1,263 Reduced 20.35%
4,942 $775 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $966,428 - $1.08 Million
6,205 New
6,205 $966 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.